News Focus
News Focus
icon url

jtsmgoblue

03/21/19 7:59 AM

#186002 RE: raja48185 #185997

For those listening, CM alluded to the possibility of this during the Roth Panel Discussion. I’m certain he was aware. Undervalued is our market cap. i have 95% of my shares out on loan for over 1.5 years. MC is surely suppressed and IMO shares being gathered up by certain MMs without reporting for some entity(s). That’s a great call on Sage partnership! I’m also predicting SG will end up in our company. Trial results await, don’t let the emotion of swings dissuade your confidence and DD. If you watched the RPD earlier this week and understand the strategic importance of the recently announced partnership you know all you need to know. No more dots need be connected.
icon url

Bourbon_on_my_cornflakes

03/21/19 12:13 PM

#186096 RE: raja48185 #185997

This BOARD knew what would happen MONTHS ago.

Biogen & Eisai to Discontinue Phase 3 Trial of aducanumab

We knew this trial would fail.

Biogen lost $20 BILLION of market cap today.

This board has been saying for months that a useful Alz treatment is worth $20 billion in market cap.

Missling said " When it is done you will understand why we did it this way." Indeed this plan and strategy seem now to be brilliant all most beyond belief!

The smart people on this board have been saying for months now that Missling, the Kellogg MBA with the Chemistry PhD, has been guiding this company to finish like Secretariat in the Belmont.

Now we are like Secretariat, so far ahead of the pack, that no one else is in sight.